Status:
COMPLETED
Influence of Bile Acids on Bacterial Uptake in Functional Dyspepsia
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Functional Dyspepsia
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
In up to half of patients seen by gastroenterologists, routine examinations fail to find an underlying organic, systemic, or metabolic disease that readily explains the symptoms. These patients are re...
Detailed Description
The participants will be expected on the department endoscopy of the University Hospital Gasthuisberg, Leuven, Belgium. They are asked to fill in a bundle of questionnaires concerning physical complai...
Eligibility Criteria
Inclusion
- Three days before the measurement: no smoking and drinking alcohol
- 12 hours before the measurement: no drinking and eating
Exclusion
- symptoms or history of gastrointestinal disease
- first degree relatives with celiac disease
- diabetes mellitus
- allergy/atopy (eczema, asthma, allergic rhinoconjunctivitis)
- coagulation disorders/anticoagulant therapy
- first degree relatives with Crohn's disease or type I diabetes mellitus.
- intake of antihistamines, ketotifen, cromoglycate, acetylsalicylates, NSAIDs, anticholinergics, theophylline, β2-agonists, codeine or opioid derivatives for at least 2 weeks prior to the gastroscopy
- Intake of steroid or immunosuppressive drugs in the last 6 months
Key Trial Info
Start Date :
January 2 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 27 2018
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03296267
Start Date
January 2 2017
End Date
August 27 2018
Last Update
July 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Translational Research center for Gastrointestinal Disorders (TARGID)
Leuven, Vlaams-Brabant, Belgium, 3000